The U.S. Securities and Exchange Commission declared effective the Form F-4 registration statement for Bleichroeder Acquisition Corp. II's business combination with Pasqal on August 5, 2026. This critical regulatory clearance removes a significant barrier, enabling Bleichroeder shareholders to vote on the merger, paving the way for Pasqal's listing and access to public capital markets for its advanced quantum computing initiatives.

Key Highlights

  • The SEC declared effective the Form F-4 registration statement for the Bleichroeder-Pasqal business combination on August 5, 2026.
  • Bleichroeder has scheduled an extraordinary general meeting for August 25, 2026, for shareholders to approve the proposed merger.
  • Pasqal, a quantum computing leader, operates systems exceeding 1,000 physical qubits and has secured over USD 300 million in funding.
  • The combined entity is expected to trade on Nasdaq under the ticker symbol PSQL upon completion.

Bleichroeder Acquisition Corp. II (NASDAQ: BBCQ) took a significant step toward completing its business combination with Pasqal Holding SAS, a prominent neutral-atom quantum computing firm, after the U.S. Securities and Exchange Commission (SEC) declared their joint registration statement on Form F-4 effective on August 5, 2026. This regulatory clearance is essential for special purpose acquisition company (SPAC) transactions, allowing Bleichroeder to proceed with a shareholder vote on the proposed merger. The move advances Pasqal toward becoming a publicly traded entity, potentially unlocking new capital for its advanced quantum technologies.

Investors now focus on the upcoming shareholder meeting, which represents the final major hurdle for the deal.

Merger Registration Clears SEC Hurdle

The SEC's declaration of effectiveness for the Form F-4 registration statement (File No. 333-296239) on August 5, 2026, marks a key moment for the Bleichroeder and Pasqal merger. This statement, originally filed on May 26, 2026, contains important information for investors, including Bleichroeder’s proxy statement and Parent Merger Sub’s prospectus related to the proposed business combination. The clearance indicates that the SEC has completed its review, allowing the formal solicitation of proxies from Bleichroeder shareholders.

This administrative approval clears a key regulatory bottleneck, positioning the merger for its final approval stages.

Transaction History and Quantum Focus

The journey toward this business combination began with an Agreement and Plan of Merger signed on February 28, 2026, and was subsequently amended on May 26, June 25, and July 22, 2026, to refine the terms. Backed by over USD 300 million in total funding, Pasqal's public listing through this SPAC merger will provide substantial resources for its ambitious technological development and market expansion plans.

Pasqal's Commercial and Technological Advances

Since announcing the proposed business combination, Pasqal has continued to demonstrate strong commercial and technological progress. Pasqal has expanded its global footprint, launching Italy’s first neutral-atom quantum computer at CINECA with a 140-qubit system, and forged strategic partnerships in Asia, including with MegazoneCloud for the South Korean market. Its collaboration with Crédit Agricole CIB in financial services highlights its focus on delivering quantum computing solutions for practical industry applications, having initiated its first commercial deployment in 2022.

Shareholder Vote Set for August 25

With the SEC clearance secured, Bleichroeder has set an extraordinary general meeting for August 25, 2026, for its shareholders to vote on the proposed business combination and related matters. Shareholders of record as of August 4, 2026, are eligible to cast their votes on the transaction. The outcome of this vote is the final significant condition to closing, determining whether Pasqal will soon join the public markets as a quantum computing innovator.

Analysis based on the Form 8-K filed 6 August 2026; figures verified against the filing.

This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.